Risk factor
Very poor trading liquidity
Profitability factor
Very low or no dividends
About
NaviFUS Corporation operates within the medical device sector, specializing in the development and commercialization of advanced focused ultrasound (FUS) technologies tailored for neurological applications. The company's primary offering is NaviFUS, a sophisticated transcranial FUS system precisely guided by neuronavigation. This innovative system is engineered to deliver concentrated energy to deep brain regions, supporting a range of clinical interventions such as enhanced drug delivery, neuromodulation, and immuno-stimulation. Additionally, NaviFUS Corp. provides NAVIRFA, a sophisticated navigation system that utilizes optical three-dimensional surgical tracking technology. Its purpose is to accurately monitor the exact placement of needle tips during various ultrasonic interventional procedures. Founded in 2015, the company's headquarters are located in Taipei, Taiwan.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers.